Literature DB >> 2555689

Transactivation of gene expression by nuclear and cytoplasmic rel proteins.

M Hannink1, H M Temin.   

Abstract

Transcriptional activation of gene expression by oncogenic proteins can lead to cellular transformation. It has recently been demonstrated that the protein encoded by the v-rel oncogene from reticuloendotheliosis virus strain T can transactivate gene expression from certain promoters in a cell-specific manner. We have examined the cytological location, transforming properties, and transactivation properties of proteins encoded by chimeric turkey v-rel/chicken c-rel genes. We found that whereas the v-rel protein was nuclear in both chicken embryo and rat fibroblasts, the presence of the C terminus of the c-rel protein inhibited nuclear localization of the rel protein in these fibroblasts. Cytoplasmic rel proteins containing C-terminal c-rel sequences transactivated gene expression from the polyomavirus late promoter as efficiently as did similar rel proteins located in the nucleus. These results indicate that the cellular location of rel proteins is not important for transactivation of gene expression and suggest that transactivation by rel proteins is indirect, perhaps by affecting an intracellular signal transduction pathway that eventually results in the alteration of gene expression. The transforming properties of the rel protein were unaltered by the presence of the c-rel C terminus, but, as previously reported for turkey c-rel sequences, substitution of chicken c-rel sequences for internal v-rel sequences reduced the transforming activity of the rel protein and eliminated the immortalization ability. However, all of the chimeric v/c-rel proteins were able to transactivate gene expression, indicating that transactivation does not correlate with transformation. These results suggest that transactivation may be necessary but is not sufficient for transformation by rel proteins.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2555689      PMCID: PMC362513          DOI: 10.1128/mcb.9.10.4323-4336.1989

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  47 in total

1.  Hematopoietic cell transformation by reticuloendotheliosis virus: characterization of the genetic defect.

Authors:  J D Hoelzer; R B Lewis; C R Wasmuth; H R Bose
Journal:  Virology       Date:  1980-01-30       Impact factor: 3.616

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Activation of the major immediate early gene of human cytomegalovirus by cis-acting elements in the promoter-regulatory sequence and by virus-specific trans-acting components.

Authors:  M F Stinski; T J Roehr
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

4.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

5.  Identification of the v-rel protein in REV-T transformed chicken bone marrow cells and expression in Cos1 cells.

Authors:  K Garson; C Y Kang
Journal:  Biochem Biophys Res Commun       Date:  1986-01-29       Impact factor: 3.575

6.  SV40-transformed simian cells support the replication of early SV40 mutants.

Authors:  Y Gluzman
Journal:  Cell       Date:  1981-01       Impact factor: 41.582

7.  Expression of the oncogene of avian reticuloendotheliosis virus in Escherichia coli and identification of the transforming protein in reticuloendotheliosis virus T-transformed cells.

Authors:  N K Herzog; H R Bose
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

8.  Detection and characterization of the protein encoded by the v-rel oncogene.

Authors:  N R Rice; T D Copeland; S Simek; S Oroszlan; R V Gilden
Journal:  Virology       Date:  1986-03       Impact factor: 3.616

9.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  44 in total

1.  The v-rel oncogene: insights into the mechanism of transcriptional activation, repression, and transformation.

Authors:  W H Walker; B Stein; P A Ganchi; J A Hoffman; P A Kaufman; D W Ballard; M Hannink; W C Greene
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

2.  c-rel activates but v-rel suppresses transcription from kappa B sites.

Authors:  J Inoue; L D Kerr; L J Ransone; E Bengal; T Hunter; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

3.  Oncogenic transformation by vrel requires an amino-terminal activation domain.

Authors:  J Kamens; P Richardson; G Mosialos; R Brent; T Gilmore
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

4.  Functional characterization of the NF-kappa B p65 transcriptional activator and an alternatively spliced derivative.

Authors:  S M Ruben; R Narayanan; J F Klement; C H Chen; C A Rosen
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

5.  A protein kinase-A recognition sequence is structurally linked to transformation by p59v-rel and cytoplasmic retention of p68c-rel.

Authors:  G Mosialos; P Hamer; A J Capobianco; R A Laursen; T D Gilmore
Journal:  Mol Cell Biol       Date:  1991-12       Impact factor: 4.272

6.  Interaction of the v-rel protein with an NF-kappa B DNA binding site.

Authors:  N Kabrun; J W Hodgson; M Doemer; G Mak; B R Franza; P J Enrietto
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

7.  Structural and functional characterization of the promoter regions of the NFKB2 gene.

Authors:  L Lombardi; P Ciana; C Cappellini; D Trecca; L Guerrini; A Migliazza; A T Maiolo; A Neri
Journal:  Nucleic Acids Res       Date:  1995-06-25       Impact factor: 16.971

8.  The reverse two-hybrid system: a genetic scheme for selection against specific protein/protein interactions.

Authors:  C A Leanna; M Hannink
Journal:  Nucleic Acids Res       Date:  1996-09-01       Impact factor: 16.971

9.  The c-rel protooncogene product c-Rel but not NF-kappa B binds to the intronic region of the human interferon-gamma gene at a site related to an interferon-stimulable response element.

Authors:  A Sica; T H Tan; N Rice; M Kretzschmar; P Ghosh; H A Young
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

10.  Distinct combinations of NF-kappa B subunits determine the specificity of transcriptional activation.

Authors:  N D Perkins; R M Schmid; C S Duckett; K Leung; N R Rice; G J Nabel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.